China Pharma Holdings Completes Trial of Generic Crestor®

China Pharma Holdings has completed its clinical trials of a generic form of a statin-family cholesterol drug, rosuvastatin. Rosuvastatin is marketed by AstraZeneca as Crestor®. China Pharma intends to obtain SFDA approval for the drug and begin selling it next year in China. More details.... Stock Symbol: (NYSE Amex: CPHI) (NYSE: AZN)